Peter Larsson

Professor Peter Larsson is affiliated with Linköping University's Department of Biomedical and Clinical Sciences, part of the Faculty of Medicine and Health Sciences. He holds a position within the Division of Cell and Neurobiology, focusing on ion channel research with clinical applications. His work bridges basic science and translational medicine, particularly in cardiac electrophysiology and neurobiological mechanisms.

Education: Not explicitly detailed in provided texts.

Research Interests: Larsson's research centers on ion channel dysfunction in disease states, including arrhythmias and epilepsy. He investigates lipid-channel interactions, drug mechanisms (e.g., propofol's effects on epilepsy), and genetic mutations' impact on cardiac and neuronal ion channels. His recent breakthrough demonstrated propofol's ability to restore function in epilepsy-linked ion channels, published in Nature.

Publications Trends: Recent work emphasizes translational drug discovery and understanding channelopathies, with contributions to eLife, British Journal of Pharmacology, and Nature. Key themes include SCN5A mutation characterization, endocannabinoid therapy for cardiac channels, and PUFA effects on potassium channels.

Awards/Grants: No specific honors or grants mentioned in available texts.

Advising: No listed advisees found. His research group appears focused on collaborative projects involving multiple institutions.

Labs/Teams: Active in the Division of Cell and Neurobiology, part of a multidisciplinary environment studying cellular structure/function and sensory systems.